<DOC>
	<DOCNO>NCT02003001</DOCNO>
	<brief_summary>The aim prospective non-randomized study ass efficacy safety endomyocardial botulinum toxin injection leave ventricle prevent ventricular arrhythmia .</brief_summary>
	<brief_title>Botulinum Toxin Injection Prevent Ventricular Arrhythmias</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Heart Arrest</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>symptomatic ventricular arrhythmia drugresistance unsuccessful one ablation procedure future unreasonable try Previous heart surgery AF ablation procedure Emergency CABG Unstable angina heart failure Use antiarrhythmic drug within 5 elimination halflives drug ( within 2 month amiodarone ) Requiring concomitant valve surgery Left ventricle ejection fraction &lt; 35 % Unwillingness participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>